⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 4, 2024

Supplementary Figure 1 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0

Chilam Chan J.H. Marco Jansen Ilona S.T. Hendriks Ida C. van der Peet Meggy E.L. Verdonschot Elsemieke M. Passchier Maria Tsioumpekou Maaike Nederend Sharon A. Klomp Thomas Valerius Matthias Peipp Jeanette H.W. Leusen Patricia A. Olofsen

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Supplementary Figure 1: Purification of IgA3.0 EGFR mAbs.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chan et al. (2024) studied this question.

synapsesocial.com/papers/68e59691b6db643587531340 https://doi.org/10.1158/1535-7163.26935095.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 1 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.02024
2Supplementary Figure 2 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.02024
3Supplementary Figure 2 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.02024
4Supplementary Figure 8 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.02024
5Supplementary Figure 8 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.02024

More related papers

Supplementary Figure 7 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.02024
Supplementary Figure 7 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.02024
Supplementary Figure 4 from Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.02024